Suchergebnisse - "Coronavirus disease 2019"

PubPharm (6)

1

Mass gatherings contributed to early COVID-19 spread : evidence from US sports

Erschienen: Linz, Austria, Johannes Kepler University, Department of Economics, Austria, June 2020

Working paper / Christian Doppler Laboratory Aging, Health, and the Labor Market - [20,03]

von Alexander, A. | Martin, H. | Lackner, M.

2

Mass gatherings contributed to early COVID-19 mortality : evidence from US sports

Erschienen: Linz-Auhof, Austria, Department of Economics, Johannes Kepler University of Linz, [2020]

Working paper / Department of Economics, Johannes Kepler University of Linz - no. 2013 (July 2020)

This version July 29, 2020

von Ahammer, A. | Halla, M. | Lackner, M.

3

Subcutaneous enoxaparin safely facilitates bedside sustained low-efficiency hemodialysis in hypercoagulopathic Coronavirus disease 2019 patients - proof-of-principle trial

sonderdruck aus: Critical care explorations | 2020

von Neumann-Haefelin, E. | Widmeier, E. | Bansbach, J. | +5

4

Coronavirus disease 2019 (COVID‐19): do angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers have a biphasic effect?

sonderdruck aus: Journal of the American Heart Association | 2020

von Sommerstein, R. | Kochen, M. | Messerli, F. | +1

5

Force majeure et COVID-19 : Une arme à double tranchant juridiquement risquée

Erschienen: Winnipeg, MN, CA, International Institute for Sustainable Development, 2020

Covid 19 Response Series

6

Does lockdown policy reduce human activity?

Erschienen: Chiba, Japan, Institute of Developing Economies (IDE), JETRO, [2020]

IDE discussion paper - no. 800

von Keola, S. | Hayakawa, K.

1
[1]